QR-Code

Emicizumab in the Treatment of Hemophilia A. Characteristics and clinical application

Introduction: Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency of factor VIII. It is characterized by a tendency for prolonged and excessive bleeding, both spontaneous and trauma-induced. The treatment of hemophilia A involves the use of factor VIII replacement thera...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Ilona Bednarek, Sylwia Lach, Aleksandra Kowalczyk, Adrian Pączek, Paweł Dyczek, Julia Hofman, Wiktoria Staniszewska, Olaf Jadanowski, Karol Seweryn Błąd
Format: Artigo
Sprache:Inglês
Veröffentlicht: Kazimierz Wielki University 2025-11-01
Schriftenreihe:Journal of Education, Health and Sport
Schlagworte:
Hemophilia A
emicizumab
pharmacokinetics
ABR
HAVEN trials
factor VIII
Online-Zugang:https://apcz.umk.pl/JEHS/article/view/66759
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge